Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Mesalamine"" wg kryterium: Temat


Tytuł :
Ni-Doped ZrO 2 nanoparticles decorated MW-CNT nanocomposite for the highly sensitive electrochemical detection of 5-amino salicylic acid.
Autorzy :
Nataraj N; Department of Chemical Engineering and Biotechnology, National Taipei University of Technology, No.1, Section 3, Chung-Hsiao East Road, Taipei 106, Taiwan. .
Krishnan SK
Chen TW
Chen SM
Lou BS
Pokaż więcej
Źródło :
The Analyst [Analyst] 2021 Jan 21; Vol. 146 (2), pp. 664-673. Date of Electronic Publication: 2020 Nov 18.
Typ publikacji :
Journal Article
MeSH Terms :
Limit of Detection*
Electrochemistry/*methods
Mesalamine/*analysis
Nanoparticles/*chemistry
Nanotubes, Carbon/*chemistry
Nickel/*chemistry
Zirconium/*chemistry
Humans ; Mesalamine/blood ; Mesalamine/urine ; Models, Molecular ; Molecular Conformation ; Nanocomposites/chemistry
Czasopismo naukowe
Tytuł :
5-aminosalicylate-intolerant patients are at increased risk of colectomy for ulcerative colitis.
Autorzy :
Hibiya S; Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.
Matsuyama Y; Department of Global Health Promotion, Tokyo Medical and Dental University, Tokyo, Japan.
Fujii T; Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.
Maeyashiki C; Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan.
Saito E; Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.
Ito K; Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.
Shimizu H; Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.
Kawamoto A; Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.
Motobayashi M; Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.
Takenaka K; Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.; Endoscopic Unit, Tokyo Medical and Dental University Hospital, Tokyo, Japan.
Nagahori M; Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.
Kurosaki M; Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan.
Yauchi T; Department of Gastroenterology, Soka Municipal Hospital, Saitama, Japan.
Ohtsuka K; Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.; Endoscopic Unit, Tokyo Medical and Dental University Hospital, Tokyo, Japan.
Fujiwara T; Department of Global Health Promotion, Tokyo Medical and Dental University, Tokyo, Japan.
Okamoto R; Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.
Watanabe M; TMDU Advanced Research Institute, Tokyo Medical and Dental University, Tokyo, Japan.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jan; Vol. 53 (1), pp. 103-113. Date of Electronic Publication: 2020 Nov 07.
Typ publikacji :
Journal Article
MeSH Terms :
Colitis, Ulcerative*/drug therapy
Colitis, Ulcerative*/surgery
Mesalamine*/adverse effects
Colectomy ; Humans ; Japan/epidemiology ; Retrospective Studies ; Risk Factors
Czasopismo naukowe
Tytuł :
Cost-Effectiveness of 5-Aminosalicylate Therapy in Combination With Biologics or Tofacitinib in the Treatment of Ulcerative Colitis.
Autorzy :
Shaffer SR; University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, Illinois, USA.
Huang E; University of Chicago Medicine, Section of General Internal Medicine, Chicago, Illinois, USA.
Patel S; University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, Illinois, USA.
Rubin DT; University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, Illinois, USA.
Pokaż więcej
Źródło :
The American journal of gastroenterology [Am J Gastroenterol] 2021 Jan 01; Vol. 116 (1), pp. 125-133.
Typ publikacji :
Journal Article
MeSH Terms :
Anti-Inflammatory Agents, Non-Steroidal/*therapeutic use
Colitis, Ulcerative/*drug therapy
Gastrointestinal Agents/*therapeutic use
Mesalamine/*therapeutic use
Piperidines/*therapeutic use
Protein Kinase Inhibitors/*therapeutic use
Pyrimidines/*therapeutic use
Anti-Inflammatory Agents, Non-Steroidal/economics ; Antibodies, Monoclonal, Humanized/economics ; Antibodies, Monoclonal, Humanized/therapeutic use ; Biological Products/economics ; Biological Products/therapeutic use ; Colitis, Ulcerative/economics ; Colitis, Ulcerative/physiopathology ; Cost-Benefit Analysis ; Deprescriptions ; Drug Therapy, Combination ; Gastrointestinal Agents/economics ; Humans ; Infliximab/economics ; Infliximab/therapeutic use ; Markov Chains ; Mesalamine/economics ; Piperidines/economics ; Protein Kinase Inhibitors/economics ; Pyrimidines/economics ; Quality-Adjusted Life Years
Czasopismo naukowe
Tytuł :
A chromatographic approach to development of 5-aminosalicylate/folic acid fixed-dose combinations for treatment of Crohn's disease and ulcerative colitis.
Autorzy :
Jeličić ML; Faculty of Pharmacy and Biochemistry, University of Zagreb, A. Kovačića 1, 10000, Zagreb, Croatia.
Brusač E; Faculty of Pharmacy and Biochemistry, University of Zagreb, A. Kovačića 1, 10000, Zagreb, Croatia.
Klarić DA; Faculty of Pharmacy and Biochemistry, University of Zagreb, A. Kovačića 1, 10000, Zagreb, Croatia.
Nigović B; Faculty of Pharmacy and Biochemistry, University of Zagreb, A. Kovačića 1, 10000, Zagreb, Croatia.
Turk N; Clinical Hospital Center Zagreb, Kišpatićeva 12, 10000, Zagreb, Croatia.
Mornar A; Faculty of Pharmacy and Biochemistry, University of Zagreb, A. Kovačića 1, 10000, Zagreb, Croatia. .
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2020 Nov 30; Vol. 10 (1), pp. 20838. Date of Electronic Publication: 2020 Nov 30.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Chromatography/*methods
Folic Acid/*pharmacokinetics
Mesalamine/*pharmacokinetics
Colitis, Ulcerative/drug therapy ; Crohn Disease/drug therapy ; Drug Combinations ; Folic Acid/chemistry ; Folic Acid/pharmacology ; Humans ; Inflammatory Bowel Diseases/drug therapy ; Mesalamine/chemistry ; Mesalamine/pharmacology ; Sulfasalazine
Czasopismo naukowe
Tytuł :
De-escalation of medical therapy in inflammatory bowel disease.
Autorzy :
Frias Gomes C; Surgical Department, Gastroenterology Division, Hospital Beatriz Ângelo, Loures, Portugal. Electronic address: .
Chapman TP; Translational Gastroenterology Unit, Nuffield Department of Experimental Medicine, University of Oxford, Oxford, UK.
Satsangi J; Translational Gastroenterology Unit, Nuffield Department of Experimental Medicine, University of Oxford, Oxford, UK.
Pokaż więcej
Źródło :
Current opinion in pharmacology [Curr Opin Pharmacol] 2020 Dec; Vol. 55, pp. 73-81. Date of Electronic Publication: 2020 Nov 05.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Biological Therapy/*methods
Immunologic Factors/*therapeutic use
Inflammatory Bowel Diseases/*drug therapy
Mesalamine/*therapeutic use
Safety-Based Drug Withdrawals/*methods
Humans ; Immunologic Factors/adverse effects ; Mesalamine/adverse effects
Czasopismo naukowe
Tytuł :
Letter: rationalising aminosalicylates in inflammatory bowel disease-authors' reply.
Autorzy :
Chapman TP; Translational Gastroenterology Unit, Nuffield Department of Experimental Medicine, University of Oxford, Oxford, UK.; Department of Gastroenterology, Western Sussex Hospitals NHS Foundation Trust, Worthing, UK.
Frias Gomes C; Surgical Department, Gastroenterology Division, Hospital Beatriz Ângelo, Loures, Portugal.
Louis E; Department of Gastroenterology, CHU Liège University Hospital, Liège, Belgium.
Colombel JF; The Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
Satsangi J; Translational Gastroenterology Unit, Nuffield Department of Experimental Medicine, University of Oxford, Oxford, UK.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2020 Nov; Vol. 52 (10), pp. 1621.
Typ publikacji :
Letter; Comment
MeSH Terms :
Inflammatory Bowel Diseases*/drug therapy
Mesalamine*
Humans
Opinia redakcyjna
Tytuł :
Induction of DNA damage, apoptosis and cell cycle perturbation mediate cytotoxic activity of new 5-aminosalicylate-4-thiazolinone hybrid derivatives.
Autorzy :
S Ramadan W; Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates; College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.
Saleh EM; Clinical Biochemistry and Molecular Biology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Egypt.
Menon V; Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates.
Vazhappilly CG; Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates.
Abdu-Allah HHM; Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Assiut University, Assiut, Egypt.
El-Shorbagi AA; College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates; Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Assiut University, Assiut, Egypt.
Mansour W; Radiobiology & Experimental Radiooncology Laboratory, Center of Oncology, University Medical Center Hamburg, Hamburg, Germany.
El-Awady R; Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates; College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates. Electronic address: .
Pokaż więcej
Źródło :
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2020 Nov; Vol. 131, pp. 110571. Date of Electronic Publication: 2020 Aug 28.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Agents/*pharmacology
Apoptosis/*drug effects
Cell Cycle/*drug effects
DNA Damage/*drug effects
Mesalamine/*pharmacology
Thiazoles/*pharmacology
A549 Cells ; Antineoplastic Agents/chemistry ; Cell Cycle/physiology ; Cell Survival/drug effects ; Cell Survival/physiology ; DNA Damage/physiology ; Dose-Response Relationship, Drug ; HeLa Cells ; Humans ; MCF-7 Cells ; Mesalamine/chemistry ; Thiazoles/chemistry
Czasopismo naukowe
Tytuł :
Letter: rationalising aminosalicylates in inflammatory bowel disease.
Autorzy :
Nicolaides S; Department of Gastroenterology, Box Hill Hospital, Eastern Health, Box Hill, Vic., Australia.
Vasudevan A; Department of Gastroenterology, Box Hill Hospital, Eastern Health, Box Hill, Vic., Australia.
van Langenberg D; Department of Gastroenterology, Box Hill Hospital, Eastern Health, Box Hill, Vic., Australia.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2020 Nov; Vol. 52 (10), pp. 1619-1620.
Typ publikacji :
Letter; Comment
MeSH Terms :
Inflammatory Bowel Diseases*/drug therapy
Mesalamine*
Humans
Opinia redakcyjna
Tytuł :
Impact of Food and Drink Administration Vehicles on Paediatric Formulation Performance Part 2: Dissolution of Montelukast Sodium and Mesalazine Formulations.
Autorzy :
Martir J; Department of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath, BA2 7AY, UK.
Flanagan T; Oral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield, UK.; UCB Pharma, Chemin du Foriest, B - 1420, Braine-l'Alleud, Belgium.
Mann J; Oral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield, UK.
Fotaki N; Department of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath, BA2 7AY, UK. .
Pokaż więcej
Źródło :
AAPS PharmSciTech [AAPS PharmSciTech] 2020 Oct 15; Vol. 21 (7), pp. 287. Date of Electronic Publication: 2020 Oct 15.
Typ publikacji :
Journal Article
MeSH Terms :
Beverages*
Food*
Acetates/*chemistry
Anti-Asthmatic Agents/*chemistry
Anti-Inflammatory Agents, Non-Steroidal/*chemistry
Mesalamine/*chemistry
Quinolines/*chemistry
Acetates/administration & dosage ; Administration, Oral ; Anti-Asthmatic Agents/administration & dosage ; Anti-Inflammatory Agents, Non-Steroidal/administration & dosage ; Biological Availability ; Child ; Drug Compounding ; Drug Liberation ; Excipients ; Humans ; Infant ; Mesalamine/administration & dosage ; Pediatrics ; Pharmaceutical Vehicles ; Quinolines/administration & dosage ; Solubility
Czasopismo naukowe
Tytuł :
Successful combination therapy using adalimumab and 5-aminosalicylic acid for a resistant case of intestinal Behçet's disease.
Autorzy :
Kim HJ; Division of Rheumatology, Department of Internal Medicine, Kosin University College of Medicine, 262 Gamcheon-Ro Seo-Gu, 49267, Busan, Korea (Republic of).
Kim KT; Division of Rheumatology, Department of Internal Medicine, Kosin University College of Medicine, 262 Gamcheon-Ro Seo-Gu, 49267, Busan, Korea (Republic of).
Lee SG; Division of Rheumatology, Department of Internal Medicine, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea (Republic of).
Kim Y; Division of Rheumatology, Department of Internal Medicine, Kosin University College of Medicine, 262 Gamcheon-Ro Seo-Gu, 49267, Busan, Korea (Republic of). .
Pokaż więcej
Transliterated Title :
Erfolgreiche Kombinationstherapie aus Adalimumab und 5-Aminosalicylsäure in einem Fall mit therapieresistentem intestinalem M. Behçet.
Źródło :
Zeitschrift fur Rheumatologie [Z Rheumatol] 2020 Sep; Vol. 79 (7), pp. 702-706.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Adalimumab*/therapeutic use
Behcet Syndrome*/drug therapy
Mesalamine*/therapeutic use
Adult ; Female ; Humans ; Infliximab ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Autorzy :
Murray A; Schulich School of Medicine & Dentistry, University of Western Ontario, London, Canada.
Nguyen TM; Robarts Clinical Trials, London, Canada.
Parker CE; Robarts Clinical Trials, London, Canada.
Feagan BG; Robarts Clinical Trials, London, Canada.; Department of Medicine, University of Western Ontario, London, Canada.; Department of Epidemiology and Biostatistics, University of Western Ontario, London, Canada.
MacDonald JK; Department of Medicine, University of Western Ontario, London, Canada.
Pokaż więcej
Źródło :
The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2020 Aug 12; Vol. 8. Cochrane AN: CD000543. Date of Electronic Publication: 2020 Aug 12.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Anti-Inflammatory Agents, Non-Steroidal/*administration & dosage
Colitis, Ulcerative/*drug therapy
Mesalamine/*administration & dosage
Sulfasalazine/*administration & dosage
Administration, Oral ; Anti-Inflammatory Agents, Non-Steroidal/adverse effects ; Bias ; Drug Administration Schedule ; Humans ; Induction Chemotherapy/methods ; Mesalamine/adverse effects ; Patient Dropouts/statistics & numerical data ; Placebos/therapeutic use ; Randomized Controlled Trials as Topic ; Remission Induction ; Sulfasalazine/adverse effects ; Treatment Failure
Czasopismo naukowe
Tytuł :
Modern use of 5-aminosalicylic acid compounds for ulcerative colitis.
Autorzy :
Le Berre C; Inserm U954 and Department of Gastroenterology, Nancy University Hospital, Université de Lorraine, Vandoeuvre-lès-Nancy, France.; Institut des Maladies de l'Appareil Digestif, Nantes University Hospital, Nantes, France.
Roda G; IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Centre, Milan, Italy.
Nedeljkovic Protic M; Tillotts Pharma AG, Rheinfelden, Switzerland.
Danese S; IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Centre, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Peyrin-Biroulet L; Inserm U954 and Department of Gastroenterology, Nancy University Hospital, Université de Lorraine, Vandoeuvre-lès-Nancy, France.
Pokaż więcej
Źródło :
Expert opinion on biological therapy [Expert Opin Biol Ther] 2020 Apr; Vol. 20 (4), pp. 363-378. Date of Electronic Publication: 2019 Sep 18.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Anti-Inflammatory Agents, Non-Steroidal/*therapeutic use
Colitis, Ulcerative/*drug therapy
Mesalamine/*therapeutic use
Anti-Inflammatory Agents, Non-Steroidal/adverse effects ; Antibodies, Monoclonal/therapeutic use ; Colitis, Ulcerative/pathology ; Gastrointestinal Diseases/etiology ; Humans ; Intestinal Mucosa/pathology ; Mesalamine/adverse effects ; Remission Induction ; Severity of Illness Index ; Tumor Necrosis Factor-alpha/immunology
Czasopismo naukowe
Tytuł :
OPTICORE™, an innovative and accurate colonic targeting technology.
Autorzy :
Varum F; Tillotts Pharma AG, Baslerstrasse 15, CH-4310 Rheinfelden, Switzerland; UCL School of Pharmacy, University College London, Brunswick Square, WC1N 1AX London, UK. Electronic address: .
Freire AC; UCL School of Pharmacy, University College London, Brunswick Square, WC1N 1AX London, UK.
Bravo R; Tillotts Pharma AG, Baslerstrasse 15, CH-4310 Rheinfelden, Switzerland.
Basit AW; UCL School of Pharmacy, University College London, Brunswick Square, WC1N 1AX London, UK.
Pokaż więcej
Źródło :
International journal of pharmaceutics [Int J Pharm] 2020 Jun 15; Vol. 583, pp. 119372. Date of Electronic Publication: 2020 Apr 25.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Bacteria/*enzymology
Colon/*microbiology
Gastrointestinal Agents/*chemistry
Mesalamine/*chemistry
Polymethacrylic Acids/*chemistry
Resistant Starch/*metabolism
Buffers ; Colon/metabolism ; Drug Compounding ; Drug Liberation ; Feces/microbiology ; Gastrointestinal Agents/metabolism ; Humans ; Hydrogen-Ion Concentration ; Intestinal Absorption ; Kinetics ; Mesalamine/metabolism ; Osmolar Concentration ; Tablets, Enteric-Coated
Czasopismo naukowe
Tytuł :
Letter: mesalazine-a safe drug with rare serious adverse events? Authors' reply.
Autorzy :
Sehgal P; Gastroenterology, Columbia Presbyterian Medical Center, New York, NY, USA.
Narula N; Division of Gastroenterology (2F59), McMaster University, Hamilton, ON, Canada.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2020 Jun; Vol. 51 (11), pp. 1212.
Typ publikacji :
Letter; Comment
MeSH Terms :
Colitis, Ulcerative*
Mesalamine*
Anti-Inflammatory Agents, Non-Steroidal ; Humans
Opinia redakcyjna
Tytuł :
Letter: mesalazine-a safe drug with rare serious adverse events.
Autorzy :
Scrivo B; IBD Unit, Villa Sofia Cervello Hospital, Palermo, Italy.
Renna S; IBD Unit, Villa Sofia Cervello Hospital, Palermo, Italy.
Casà A; IBD Unit, Villa Sofia Cervello Hospital, Palermo, Italy.
Monachino N; IBD Unit, Villa Sofia Cervello Hospital, Palermo, Italy.
Macaluso FS; IBD Unit, Villa Sofia Cervello Hospital, Palermo, Italy.
Orlando A; IBD Unit, Villa Sofia Cervello Hospital, Palermo, Italy.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2020 Jun; Vol. 51 (11), pp. 1210-1211.
Typ publikacji :
Letter; Comment
MeSH Terms :
Colitis, Ulcerative*
Mesalamine*
Anti-Inflammatory Agents, Non-Steroidal ; Humans
Opinia redakcyjna
Tytuł :
Transport characteristics of 5-aminosalicylic acid into colonic epithelium: Involvement of sodium-coupled monocarboxylate transporter SMCT1-mediated transport system.
Autorzy :
Yuri T; Graduate School of Pharmaceutical Sciences, Ritsumeikan University, Shiga, Japan.
Kono Y; Graduate School of Pharmaceutical Sciences, Ritsumeikan University, Shiga, Japan; Ritsumeikan Global-Innovation Research Organization, Ritsumeikan University, Shiga, Japan.
Fujita T; Graduate School of Pharmaceutical Sciences, Ritsumeikan University, Shiga, Japan; Ritsumeikan Global-Innovation Research Organization, Ritsumeikan University, Shiga, Japan; Research Center for Drug Discovery and Development, Ritsumeikan University, Shiga, Japan. Electronic address: .
Pokaż więcej
Źródło :
Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2020 Apr 09; Vol. 524 (3), pp. 561-566. Date of Electronic Publication: 2020 Jan 31.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Intestinal Mucosa/*metabolism
Mesalamine/*metabolism
Monocarboxylic Acid Transporters/*metabolism
Animals ; Biological Transport ; Ibuprofen/metabolism ; Lactic Acid/metabolism ; Male ; Mesalamine/chemistry ; Mice, Inbred ICR ; Niacin/metabolism ; Sodium/metabolism ; Substrate Specificity ; Tritium/metabolism
Czasopismo naukowe
Tytuł :
Does the 5-Aminosalicylate Concentration Correlate with the Efficacy of Oral 5-Aminosalicylate and Predict Response in Patients with Inflammatory Bowel Disease? A Systematic Review.
Autorzy :
van de Meeberg MM; Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands, .; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands, .
Schultheiss JPD; Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Oldenburg B; Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Fidder HH; Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Huitema ADR; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Department of Pharmacy and Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Pokaż więcej
Źródło :
Digestion [Digestion] 2020; Vol. 101 (3), pp. 245-261. Date of Electronic Publication: 2019 Apr 23.
Typ publikacji :
Journal Article; Systematic Review
MeSH Terms :
Anti-Inflammatory Agents, Non-Steroidal/*analysis
Colitis, Ulcerative/*drug therapy
Drug Monitoring/*methods
Mesalamine/*analysis
Administration, Oral ; Anti-Inflammatory Agents, Non-Steroidal/administration & dosage ; Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics ; Biological Availability ; Colitis, Ulcerative/pathology ; Colon/chemistry ; Colon/pathology ; Feces/chemistry ; Humans ; Intestinal Mucosa/chemistry ; Intestinal Mucosa/pathology ; Mesalamine/administration & dosage ; Mesalamine/pharmacokinetics ; Treatment Outcome
Czasopismo naukowe
Tytuł :
[ Huangqin decoction alleviates ulcerative colitis by regulating ILC3s-TH cell response].
Autorzy :
Zhou C; First Clinical Medical College, Guangdong Medical University, Zhanjiang 524023, China.
Zheng X; School Of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.; Dongguan Mathematical Engineering Academy of Chinese Medicine, Guangzhou University Chinese Medicine, Dongguan 523000, China.
Huang X; School Of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.; Dongguan Mathematical Engineering Academy of Chinese Medicine, Guangzhou University Chinese Medicine, Dongguan 523000, China.
Su J; Research Laboratory, Foshan Women and Children's Hospital, Affiliated Foshan Women and Children's Hospital of Southern Medical University, Foshan 528000, China.
Li M; School Of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
Chen Z; Dongguan Mathematical Engineering Academy of Chinese Medicine, Guangzhou University Chinese Medicine, Dongguan 523000, China.
Li M; School Of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
Chi H; Second School of Clinical Medicine, Guangdong Medical University, Dongguan 523000, China.
Pokaż więcej
Źródło :
Nan fang yi ke da xue xue bao = Journal of Southern Medical University [Nan Fang Yi Ke Da Xue Xue Bao] 2021 Feb 25; Vol. 41 (2), pp. 256-263.
Typ publikacji :
Journal Article
MeSH Terms :
Colitis, Ulcerative*/drug therapy
Animals ; Cell Count ; Immunity, Innate ; Male ; Mesalamine/therapeutic use ; Mice ; Scutellaria baicalensis
Czasopismo naukowe
Tytuł :
Effect of Kangfuxin Liquid enema combined with mesalazine on gestational outcomes and quality of life in child-bearing female with active ulcerative colitis: A protocol for randomized, double-blind, controlled trial.
Autorzy :
Wang T; College of Clinical Medicine, Chengdu University of Traditional Chinese Medicine.
Lu H; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, P.R. China.
Li F; College of Clinical Medicine, Chengdu University of Traditional Chinese Medicine.
Zhang Q; College of Clinical Medicine, Chengdu University of Traditional Chinese Medicine.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2021 Feb 05; Vol. 100 (5), pp. e23915.
Typ publikacji :
Clinical Trial Protocol; Journal Article
MeSH Terms :
Anti-Inflammatory Agents, Non-Steroidal/*administration & dosage
Colitis, Ulcerative/*drug therapy
Enema/*methods
Materia Medica/*administration & dosage
Mesalamine/*administration & dosage
Pregnancy Complications/*drug therapy
Adult ; Colitis, Ulcerative/complications ; Double-Blind Method ; Female ; Humans ; Middle Aged ; Pregnancy ; Pregnancy Complications/etiology ; Pregnancy Outcome ; Quality of Life ; Randomized Controlled Trials as Topic ; Treatment Outcome ; Young Adult
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies